Eric D Miller1, Dukagjin M Blakaj1, Benjamin J Swanson2, Weihong Xiao3, Maura L Gillison3, Lai Wei4, Aashish D Bhatt1, Virginia M Diavolitsis1, Jessica L Wobb1, Stephen Y Kang5, Ricardo L Carrau5, John C Grecula1. 1. Department of Radiation Oncology, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. 2. Department of Pathology, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. 3. Department of Viral Oncology, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. 4. Center for Biostatistics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. 5. Department of Otolaryngology, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Abstract
BACKGROUND: The purpose of this study was to review long-term outcomes of sinonasal adenoid cystic carcinoma (ACC) and to clarify its association with human papillomavirus (HPV). METHODS: The medical records of 23 patients with sinonasal ACC treated with primary surgical resection between 1998 and 2013 were reviewed. Tissue specimens were available for 17 patients. The p16 testing was performed using immunohistochemistry (IHC), and HPV infection was determined using quantitative polymerase chain reaction (PCR) with primers targeting the E6/E7 region. RESULTS: Two of the 17 samples showed strong and diffuse p16 staining, whereas the remaining 15 cases showed p16-positivity isolated to the luminal cells. Only one of the p16-positive cases was positive for HPV. The 5-year local failure, disease-free survival (DFS), and overall survival (OS) were 51%, 52%, and 62%, respectively. CONCLUSION: Local failures are common with advanced sinonasal ACC, and the association of HPV with true sinonasal ACC is low.
BACKGROUND: The purpose of this study was to review long-term outcomes of sinonasal adenoid cystic carcinoma (ACC) and to clarify its association with human papillomavirus (HPV). METHODS: The medical records of 23 patients with sinonasal ACC treated with primary surgical resection between 1998 and 2013 were reviewed. Tissue specimens were available for 17 patients. The p16 testing was performed using immunohistochemistry (IHC), and HPV infection was determined using quantitative polymerase chain reaction (PCR) with primers targeting the E6/E7 region. RESULTS: Two of the 17 samples showed strong and diffuse p16 staining, whereas the remaining 15 cases showed p16-positivity isolated to the luminal cells. Only one of the p16-positive cases was positive for HPV. The 5-year local failure, disease-free survival (DFS), and overall survival (OS) were 51%, 52%, and 62%, respectively. CONCLUSION: Local failures are common with advanced sinonasal ACC, and the association of HPV with true sinonasal ACC is low.
Authors: Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison Journal: J Clin Oncol Date: 2011-10-03 Impact factor: 44.544
Authors: Richard C Jordan; Mark W Lingen; Bayardo Perez-Ordonez; Xin He; Robert Pickard; Michael Koluder; Bo Jiang; Paul Wakely; Weihong Xiao; Maura L Gillison Journal: Am J Surg Pathol Date: 2012-07 Impact factor: 6.394
Authors: Justin A Bishop; Takenori Ogawa; Edward B Stelow; Christopher A Moskaluk; Wayne M Koch; Sara I Pai; William H Westra Journal: Am J Surg Pathol Date: 2013-06 Impact factor: 6.394
Authors: Patti E Gravitt; Robert D Burk; Attila Lorincz; Rolando Herrero; Allan Hildesheim; Mark E Sherman; Maria Concepcion Bratti; Ana Cecilia Rodriguez; Kathy J Helzlsouer; Mark Schiffman Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-06 Impact factor: 4.254
Authors: J D Palmer; M E Gamez; K Ranta; H Ruiz-Garcia; J L Peterson; D M Blakaj; D Prevedello; R Carrau; A Mahajan; K L Chaichana; D M Trifiletti Journal: J Neurooncol Date: 2020-08-12 Impact factor: 4.130